142 related articles for article (PubMed ID: 38290824)
21. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
[TBL] [Abstract][Full Text] [Related]
22. Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation.
Farschtschi S; Mautner VF; Hollants S; Hagel C; Spaepen M; Schulte C; Legius E; Brems H
BMC Med Genet; 2015 Feb; 16():6. PubMed ID: 25928347
[TBL] [Abstract][Full Text] [Related]
23. Combined melanocytic and sweat gland neoplasm: cell subsets harbor an identical HRAS mutation in phacomatosis pigmentokeratotica.
Li JY; Berger MF; Marghoob A; Bhanot UK; Toyohara JP; Pulitzer MP
J Cutan Pathol; 2014 Aug; 41(8):663-71. PubMed ID: 24628623
[TBL] [Abstract][Full Text] [Related]
24. Epidermal Nevi and Related Syndromes -- Part 1: Keratinocytic Nevi.
Garcias-Ladaria J; Cuadrado Rosón M; Pascual-López M
Actas Dermosifiliogr (Engl Ed); 2018 Oct; 109(8):677-686. PubMed ID: 29983155
[TBL] [Abstract][Full Text] [Related]
25. Phacomatosis pigmentokeratotica is a "pseudodidymosis".
Happle R
J Invest Dermatol; 2013 Aug; 133(8):1923-5. PubMed ID: 23856930
[TBL] [Abstract][Full Text] [Related]
26. Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi.
Bender RP; McGinniss MJ; Esmay P; Velazquez EF; Reimann JD
Mod Pathol; 2013 Oct; 26(10):1320-8. PubMed ID: 23599145
[TBL] [Abstract][Full Text] [Related]
27. Epidermal, sebaceous, and melanocytic nevoid proliferations are spectrums of mosaic RASopathies.
Luo S; Tsao H
J Invest Dermatol; 2014 Oct; 134(10):2493-2496. PubMed ID: 25219651
[TBL] [Abstract][Full Text] [Related]
28. Epidermal Nevi and Related Syndromes - Part 2: Nevi Derived from Adnexal Structures.
Garcias-Ladaria J; Cuadrado Rosón M; Pascual-López M
Actas Dermosifiliogr (Engl Ed); 2018 Oct; 109(8):687-698. PubMed ID: 30041869
[TBL] [Abstract][Full Text] [Related]
29. Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum.
Shen AS; Peterhof E; Kind P; Rütten A; Zelger B; Landthaler M; Berneburg M; Hafner C; Groesser L
Hum Pathol; 2015 Feb; 46(2):272-6. PubMed ID: 25532942
[TBL] [Abstract][Full Text] [Related]
30. Epidermal nevus syndromes: New insights into whorls and swirls.
Asch S; Sugarman JL
Pediatr Dermatol; 2018 Jan; 35(1):21-29. PubMed ID: 29044700
[TBL] [Abstract][Full Text] [Related]
31. Keratinocytic epidermal nevi are associated with mosaic RAS mutations.
Hafner C; Toll A; Gantner S; Mauerer A; Lurkin I; Acquadro F; Fernández-Casado A; Zwarthoff EC; Dietmaier W; Baselga E; Parera E; Vicente A; Casanova A; Cigudosa J; Mentzel T; Pujol RM; Landthaler M; Real FX
J Med Genet; 2012 Apr; 49(4):249-53. PubMed ID: 22499344
[TBL] [Abstract][Full Text] [Related]
32. Bilateral Nephroblastic Tumors and a Complex Renal Vascular Anomaly in a Patient With a Mosaic RASopathy: Novel Histopathologic Features and Molecular Insights.
Slack JC; Bründler MA; Chang CA; Perrier R; Lafay-Cousin L; Kurek KC
Pediatr Dev Pathol; 2021; 24(3):235-240. PubMed ID: 33538228
[TBL] [Abstract][Full Text] [Related]
33. Phacomatosis pigmentokeratotica: a further case without extracutaneous anomalies and review of the condition.
Chantorn R; Shwayder T
Pediatr Dermatol; 2011; 28(6):715-719. PubMed ID: 22082467
[TBL] [Abstract][Full Text] [Related]
34. A case of woolly hair nevus, multiple linear pigmentation, and epidermal nevi with somatic HRAS p.G12S mutation.
Nishihara K; Tohyama M; Kubo A
Pediatr Dermatol; 2019 May; 36(3):368-371. PubMed ID: 30864170
[TBL] [Abstract][Full Text] [Related]
35. Widespread keratinocytic epidermal nevus with an associated chylous pericardial effusion.
Rowe G; Snyder KM; Treat JR
Pediatr Dermatol; 2023; 40(5):962-963. PubMed ID: 37232077
[TBL] [Abstract][Full Text] [Related]
36. Giant congenital melanocytic nevus with vascular malformation and epidermal cysts associated with a somatic activating mutation in BRAF.
Etchevers HC; Rose C; Kahle B; Vorbringer H; Fina F; Heux P; Berger I; Schwarz B; Zaffran S; Macagno N; Krengel S
Pigment Cell Melanoma Res; 2018 May; 31(3):437-441. PubMed ID: 29316280
[TBL] [Abstract][Full Text] [Related]
37. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
38. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
[TBL] [Abstract][Full Text] [Related]
39. Novel findings and expansion of phenotype in a mosaic RASopathy caused by somatic KRAS variants.
Chang CA; Perrier R; Kurek KC; Estrada-Veras J; Lehman A; Yip S; Hendson G; Diamond C; Pinchot JW; Tran JM; Arkin LM; Drolet BA; Napier MP; O'Neill SA; Balci TB; Keppler-Noreuil KM
Am J Med Genet A; 2021 Sep; 185(9):2829-2845. PubMed ID: 34056834
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
